SCHEMBL12835528

SCHEMBL12835528

CCc1ccc(-c2c(F)c(F)c(F)c(F)c2F)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.43
EGFR P00533 1/20 0.41
TP53 P04637 2/20 0.40
TAAR1 Q96RJ0 1/20 0.39
METAP2 P50579 1/20 0.38
CYP2A6 P11509 1/20 0.38
LPL P06858 1/20 0.38
LIPG Q9Y5X9 1/20 0.38
L3MBTL1 Q9Y468 2/20 0.37
NISCH Q9Y2I1 1/20 0.37
ALDH1A1 P00352 1/20 0.37
UCHL1 P09936 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
CA2 P00918 1/20 0.35
TSHR P16473 1/20 0.35
MAPK1 P28482 1/20 0.35
ATM Q13315 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
NOTUM Q6P988 1/20 0.35
NPC1 O15118 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19182654 0.87 LMNA (0.38) LMNAEGFRTP53TAAR1METAP2
SCHEMBL25847318 0.80 CYP1A2 (0.52) LMNATP53CYP2A6ALDH1A1SMN1; SMN2
SCHEMBL9559509 0.79 LPL (0.43) TP53LPLLIPGNISCHALDH1A1
SCHEMBL4159679 0.79 TTR (0.32)
SCHEMBL23051728 0.78 GABRA1 (0.42) LMNAEGFRCYP2A6SMN1; SMN2
SCHEMBL22909496 0.78 LMNA (0.33) LMNAEGFRNISCH
SCHEMBL26188086 0.78 CYP2A6 (0.39) LMNAEGFRTP53METAP2CYP2A6
SCHEMBL9318418 0.78 TAAR1 (0.35) LMNAEGFRTP53TAAR1METAP2
SCHEMBL12190329 0.77 TAAR1 (0.41) LMNAEGFRTP53TAAR1METAP2
SCHEMBL11671752 0.77 TTR (0.47) LMNAEGFRTP53TAAR1METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8470961-B2 Naphtalene-imide semiconductor polymers BASF SE (DE) 2013-06-25 US disclosed
US-7902363-B2 Novel air stable and solution processable n-type compounds such as n,n'-bis[3,7-dimethyl-6-octenyl]-1,7-dicyanoperylene-3,4:9,10-bis(dicarboxiamide); complementary circuits, organic light emitting diodes and photovoltaics, capacitors, sensors POLYERA CORPORATION (US) 2011-03-08 US disclosed
US-20080185577-A1 Diimide-based semiconductor materials and methods of preparing and using the same USINVEST LLC 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080185577-A1 Diimide-based semiconductor materials and methods of preparing and using the same DDT, INMT, PIR LMNA 2861/4885EGFR 3060/4885TP53 3025/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.